Valiant Organics files FY26 investor presentation, PAT INR 332 Mn
Valiant Organics Limited filed an investor presentation for Q4 and FY26 ended March 31, 2026. The company returned to profitability with a PAT of INR 332 million and an EBITDA margin of 11.94%. Operational revenue rose 2.8% to INR 7,388 million, driven by stable demand and cost optimization.

*this image is generated using AI for illustrative purposes only.
Valiant Organics Limited filed an investor presentation for the quarter and year ended March 31, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported a return to profitability in FY26 with a Profit After Tax (PAT) of INR 332 million compared to a net loss of INR 34 million in the previous year. The turnaround was driven by focused operational execution and structural cost optimization initiatives, which led to an EBITDA margin expansion of 447 basis points to 11.94%.
Operational revenue for FY26 increased by 2.8% year-on-year to INR 7,388 million, supported by stable demand and improved realizations across key product categories. The company’s financial performance improved significantly in the fourth quarter, with operational revenue rising 36.7% quarter-on-quarter to INR 2,178 million. PAT for Q4-FY26 reached INR 157 million, while the EBITDA margin for the quarter stood at 12.17%.
Consolidated Financial Performance
The annual results show a robust recovery across key profitability metrics. EBITDA for FY26 surged 64.2% to INR 882 million from INR 537 million in FY25. The company’s PAT margin improved to 4.49% from a negative 0.47% in the prior year. Basic and Diluted EPS for FY26 was reported at INR 11.86 per share, compared to INR (1.24) per share in FY25.
| Particulars (INR Mn) | FY26 | FY25 | Y-o-Y |
|---|---|---|---|
| Revenue from Operations | 7,388 | 7,188 | 2.8% |
| EBITDA | 882 | 537 | 64.2% |
| EBITDA Margins (%) | 11.94% | 7.47% | 447 Bps |
| PAT | 332 | (34) | NA |
| PAT Margins (%) | 4.49% | (0.47)% | 496 Bps |
Segment and Operational Highlights
Revenue contributions were led by the Hydrogenation chemistry segment, which accounted for 48% of total sales, followed by Ammonolysis at 26% and Chlorination at 20%. By end-user industry, Dyes & Pigments represented the largest segment at 45%, followed by Agro Chemicals at 24% and Pharmaceuticals at 21%. The company operates six manufacturing units across five locations with a total production capacity of 70,000 TPA.
Balance Sheet and Ratios
The company’s net worth stood at INR 5,882 million as of March 31, 2026, while the net debt to equity ratio remained stable at 0.33x. Return on Capital Employed (ROCE) improved to 5.52% in FY26 from 2.72% in the previous year, and Return on Equity (ROE) turned positive at 4.37% compared to (0.47)% in FY25.
Historical Stock Returns for Valiant Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.13% | -0.36% | -7.52% | +2.28% | -33.22% | -81.96% |
What are the company's plans for capital allocation following the return to profitability?
Will the structural cost optimization initiatives be sustained to maintain current EBITDA margins?
Are there plans to expand production capacity given the strong Q4 performance?































